Navigation Links
Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate

ic patients with chronic kidney disease who are not on dialysis. Additionally, data showing the equivalence of sevelamer carbonate and sevelamer hydrochloride were presented at the 2007 spring clinical meeting of the National Kidney Foundation.

About Renagel

Renagel controls serum phosphorus in patients with CKD on hemodialysis. Controlling serum phosphorus is an important element in the care of hemodialysis patients. Elevated serum phosphorus levels are common in dialysis patients and associated with increased risk of cardiovascular mortality. Renagel provides the added benefit of significant LDL cholesterol reduction (32 percent).

The National Kidney Foundation’s 2003 K/DOQI guidelines for Bone Metabolism and Disease in Chronic Kidney Disease recommend sevelamer hydrochloride as a first-line treatment option to control phosphorus. Renagel is the only phosphate binder available that does not contain either calcium or a metal. It has an established safety profile, is not systemically absorbed and provides phosphorus control without the concerns of calcium or metal accumulation. Renagel is used by more than 350,000 people worldwide.

Renagel is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on hemodialysis. Renagel is contraindicated in patients with hypophosphatemia or bowel obstruction. In a 52-week study, the most common side effects included vomiting, nausea, diarrhea, and dyspepsia. Drug-drug interactions may occur with some medications and should be taken into consideration when instructing patients how to take Renagel.

For more information about Renagel, including complete prescribing information, please visit www.renagel.com.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/24/2009)...re-FirstCall/--KeryxBiopharmaceuticals,Inc.(Nasdaq...hiefExecutiveOfficer,isscheduledtopresentatthePipe...ewYorkCity. ,, Mr.Bentsur,spresentationwillbewe...beaccessiblefromtheInvestorInformationpageoftheCom...ivedversionofthewebcastwillbeavailablefollowingthe...
(Date:11/23/2009)...swire-USNewswire/--FebeDurango-Rueda,52,aColombian...ginaschemetodefraudtheExport-ImportBankoftheUnited...stantAttorneyGeneraloftheCriminalDivisionLannyA.Br...eEx-ImBank,OfficeoftheInspectorGeneral. ,, Dura...istrictCourtinWashingtontoaone-countcriminalinform...
(Date:11/23/2009)...ewswire-FirstCall/--BostonScientificCorporation(NY...HealthCareConference,December1-2. ,, RayElliott...tiveVicePresidentandChiefFinancialOfficer,willpart...day,December1st,beginningatapproximately9:00a.m.E....letoallinterestedpartiesatBostonScientific,swebsit...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2
...o 450 days in patients who received eith...rch 29 The investigational,antiplatelet drug pras...atistically significant reduction in the risk of c...r physicians and patients with,potentially fatal c...compared to standard therapy with clopidogrel (Pla...
...ytherapy as NeoVista Progresses wit...ch 28 NeoVista, Inc. released,today to the eye co...y,study of the company,s novel epiretinal brachyth...neration (AMD) at the 31st Annual Macula Society,M...from the study, which,was initiated by NeoVista to...
Other Medicine Technology:Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 2NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 3
(Date:11/24/2009)...NAPOLIS Involving family members of pediatric can...fits both the family and the medical team, accordi...study. , Riley Hospital for Children, where the...umber of hospitals nationwide routinely offering t...ents the opportunity to join their child,s medical...
(Date:11/24/2009)... ability reduced in those with undesirable blood l...24 (HealthDay News) -- Abnormal cholesterol levels...ure, a new study has found. , U.S. researchers ...l Heart, Lung, and Blood Institute,s Framingham He...4, had coronary heart disease at the start of the ...
(Date:11/24/2009)... Laser-type device to be coupled... San Diego, CA (PRWEB) November 24, 2009 -- Ente...it has initiated discussions with a manufacturer o...y laser device which shall be owned by Entest and ...es currently being developed by Entest. These ther...
(Date:11/24/2009)... Web content and Internet market...free leads through your website. , ...en another tough year for the U.S. economy. Small ...ng the strain to keep their businesses afloat and ...pping block are things like training or marketing ...
(Date:11/24/2009)... 2009Q3Financials,S-1RegistrationStatementbeingPr... ,, WESTON,Fla.,Nov.24/PRNewswire-FirstCall/--...theCompany")ispleasedtomakeavailableacurrentcorpor...ncialsonPinksheetsrecently,ASRhasbeendiligentinacc...rmbusinessplanfortheCompany. ,, Aspartofthisong...
Breaking Medicine News(10 mins):Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3
...an Lunden, the nation,s,longest-running morning ne...arly two decades. During her tenure she reported ...lympics, and two Royal weddings. One of the most,...national media campaigns. Lunden,s years in broad...
...welling, loose teeth and exposed bone , , ...n of people taking widely prescribed oral osteopor...e much higher than previously thought, a new study...ible," although there was a noted risk in people t...
... discovered a new syndrome associated with severe ...hich children lack sufficient infection-fighting w...e syndrome: mutations in the gene Glucose-6-phosph... an international team of scientists, composed of ...
...rsity Of Southern California, School Of Dentistry ...isphosphonates to increased jaw necrosis. The stud...t-term use of common oral osteoporosis drugs may l...A ). , Osteoporosis currently affects 10 million ...
...of salicylic acid in study participants , ... acid, the key component that gives aspirin its an... be something humans can produce on their own, a n.... This made sense because salicylic acid is a nat...
...tudy shows that people who are smokers and have a ...ificantly more likely to suffer a stroke from a br... in the December 31, 2008, online issue of Neurol...ke, called subarachnoid hemorrhage, is one of the ...
Other Medicine News:Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 3Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 2Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 3Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Smokers with stroke in the family 6 times more likely to have stroke too 2
Bandeau Bra
Medical Cotton Bra
Compression Bra
Universal Breast Augmentation Support
Medicine Products: